7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      In vivo ratiometric optical mapping enables high-resolution cardiac electrophysiology in pig models

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          Cardiac optical mapping is the gold standard for measuring complex electrophysiology in ex vivo heart preparations. However, new methods for optical mapping in vivo have been elusive. We aimed at developing and validating an experimental method for performing in vivo cardiac optical mapping in pig models.

          Methods and results

          First, we characterized ex vivo the excitation-ratiometric properties during pacing and ventricular fibrillation (VF) of two near-infrared voltage-sensitive dyes (di-4-ANBDQBS/di-4-ANEQ(F)PTEA) optimized for imaging blood-perfused tissue ( n = 7). Then, optical-fibre recordings in Langendorff-perfused hearts demonstrated that ratiometry permits the recording of optical action potentials (APs) with minimal motion artefacts during contraction ( n = 7). Ratiometric optical mapping ex vivo also showed that optical AP duration (APD) and conduction velocity (CV) measurements can be accurately obtained to test drug effects. Secondly, we developed a percutaneous dye-loading protocol in vivo to perform high-resolution ratiometric optical mapping of VF dynamics (motion minimal) using a high-speed camera system positioned above the epicardial surface of the exposed heart ( n = 11). During pacing (motion substantial) we recorded ratiometric optical signals and activation via a 2D fibre array in contact with the epicardial surface ( n = 7). Optical APs in vivo under general anaesthesia showed significantly faster CV [120 (63–138) cm/s vs. 51 (41–64) cm/s; P = 0.032] and a statistical trend to longer APD 90 [242 (217–254) ms vs. 192 (182–233) ms; P = 0.095] compared with ex vivo measurements in the contracting heart. The average rate of signal-to-noise ratio (SNR) decay of di-4-ANEQ(F)PTEA in vivo was 0.0671 ± 0.0090 min −1. However, reloading with di-4-ANEQ(F)PTEA fully recovered the initial SNR. Finally, toxicity studies ( n = 12) showed that coronary dye injection did not generate systemic nor cardiac damage, although di-4-ANBDQBS injection induced transient hypotension, which was not observed with di-4-ANEQ(F)PTEA.

          Conclusions

          In vivo optical mapping using voltage ratiometry of near-infrared dyes enables high-resolution cardiac electrophysiology in translational pig models.

          Graphical Abstract

          Graphical Abstract

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Optical imaging of voltage and calcium in cardiac cells & tissues.

          Cardiac optical mapping has proven to be a powerful technology for studying cardiovascular function and disease. The development and scientific impact of this methodology are well-documented. Because of its relevance in cardiac research, this imaging technology advances at a rapid pace. Here, we review technological and scientific developments during the past several years and look toward the future. First, we explore key components of a modern optical mapping set-up, focusing on: (1) new camera technologies; (2) powerful light-emitting-diodes (from ultraviolet to red) for illumination; (3) improved optical filter technology; (4) new synthetic and optogenetic fluorescent probes; (5) optical mapping with motion and contraction; (6) new multiparametric optical mapping techniques; and (7) photon scattering effects in thick tissue preparations. We then look at recent optical mapping studies in single cells, cardiomyocyte monolayers, atria, and whole hearts. Finally, we briefly look into the possible future roles of optical mapping in the development of regenerative cardiac research, cardiac cell therapies, and molecular genetic advances.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Mechanisms of cardiac fibrillation.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts.

              Application of fluorescence imaging of cardiac electrical activity is limited by motion artifacts and/or side effects of currently available pharmacologic excitation-contraction uncoupling agents. The purpose of this study was to test whether blebbistatin, a recently discovered inhibitor of myosin II isoforms, can be used as an excitation-contraction uncoupler. The specificity and potency of blebbistatin were examined by assaying the effects of blebbistatin on the contraction and basic cardiac electrophysiologic parameters of Langendorff-perfused rabbit hearts, isolated rabbit right ventricle and right atrium, and single rat ventricular myocytes using conventional ECG, surface electrograms, microelectrode recordings, and optical imaging with voltage-sensitive and Ca(2+)-sensitive dyes. Action potential morphology, ECG parameters, cardiac conduction, and refractoriness were determined after perfusion with 0.1-10 microM blebbistatin. Blebbistatin 5-10 microM completely eliminated contraction in all cardiac preparations but did not have any effect on electrical activity, including ECG parameters, atrial and ventricular effective refractory periods, and atrial and ventricular activation patterns. Blebbistatin 10 microM had no effects on action potential morphology in rabbit cardiac tissue. Blebbistatin inhibited single cellular contraction in a dose-dependent manner with half-maximal inhibitory concentration (IC(50)) = 0.43 microM, without altering the morphologies of intracellular calcium transients. The blebbistatin effect was completely reversible by simultaneous washout and photobleaching by ultraviolet light Blebbistatin is a promising novel selective excitation-contraction uncoupler that can be used for optical imaging of cardiac tissues.
                Bookmark

                Author and article information

                Journal
                Cardiovasc Res
                Cardiovasc. Res
                cardiovascres
                Cardiovascular Research
                Oxford University Press
                0008-6363
                1755-3245
                01 September 2019
                07 February 2019
                07 February 2019
                : 115
                : 11
                : 1659-1671
                Affiliations
                [1 ]Essel Research and Development Inc., Toronto, 337 Sheppard Ave East, Toronto, Ontario M2N 3B3, Canada
                [2 ]Spanish National Cardiovascular Research Center, Carlos III (CNIC), Myocardial Pathophysiology Area, Melchor Fernández Almagro, 3, Madrid, Spain
                [3 ]Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Av. Monforte de Lemos 3-5, Madrid, Spain
                [4 ]Arrhythmia Unit, Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Prof. Martín Lagos s/n, Madrid, Spain
                [5 ]Richard D. Berlin Center for Cell Analysis and Modeling, University of Connecticut School of Medicine, 263 Farmington Avenue, Farmington, CT, USA
                [6 ]Philips Healthcare Iberia, María de Portugal 1, Madrid, Spain
                [7 ]Fundación Interhospitalaria para la Investigación Cardiovascular (FIC), Paseo de San Francisco de Sales 3, Madrid, Spain
                [8 ]IIS-University Hospital Fundación Jiménez Díaz, Department of Cardiology, Av. Reyes Católicos 2, Madrid, Spain
                Author notes
                Corresponding authors. Tel: (860) 679 3568; fax: (860) 679 1039, E-mail: les@ 123456uchc.edu (L.M.L.); Tel:+34 914531200; fax: +34 91 4531265, E-mail: david.filgueiras@ 123456cnic.es (D.F.-R.)

                Joint first authors. Peter Lee and Jorge G. Quintanilla authors contributed equally to this work.

                Article
                cvz039
                10.1093/cvr/cvz039
                6704389
                30753358
                231af401-b88d-4c8e-90dc-9917e21f020b
                © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 21 May 2018
                : 31 January 2019
                : 06 February 2019
                Page count
                Pages: 13
                Funding
                Funded by: Ministry of Science
                Funded by: Innovation and Universities
                Funded by: Pro CNIC Foundation
                Funded by: CNIC is a Severo Ochoa Center of Excellence
                Award ID: SEV-2015-0505
                Funded by: Fondo Europeo de Desarrollo Regional 10.13039/501100008530
                Award ID: CB16/11/00458
                Funded by: Spanish Ministry of Science, Innovation and Universities
                Award ID: SAF2016-80324-R
                Award ID: PI16/02110
                Award ID: DTS17/00136
                Funded by: European Commission 10.13039/501100000780
                Award ID: AC16/00021
                Funded by: Fundación Interhospitalaria para la Investigación Cardiovascular
                Funded by: FIC 10.13039/100000061
                Funded by: Spanish Society of Cardiology 10.13039/100009664
                Award ID: EB001963
                Funded by: National Institutes of Health 10.13039/100000002
                Categories
                Original Articles
                Novel Methodology

                Cardiovascular Medicine
                in vivo imaging,optical mapping,voltage-sensitive dyes,cardiac fibrillation,cardiotoxicity

                Comments

                Comment on this article